EP2917232
Faktor VIII-afleidd peptíð til notkunar við meðhöndlun á dreyrasýki A
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
11.11.2013EP published:
1.3.2017EP application number:
13795002.8
EP translation filed:
29.5.2017Grant published:
15.6.2017EPO information:
European Patent Register
Max expiry date:
10.11.2033Expiry date:
10.11.2019
Title:
FACTOR VIII-DERIVED PEPTIDES FOR USE IN THE TREATMENT OF HAEMOPHILIA A
Timeline
Today
11.11.2013EP application
1.3.2017EP Publication
29.5.2017Translation submitted
15.6.2017Registration published
10.11.2019Expires
Owner
Name:
Apitope International NVAddress:
Campus Diepenbeek Agoralaan, 3590, Diepenbeek, BE
Inventor
Name:
WRAITH, DavidAddress:
Bristol BS8 1TD, GB
Name:
STREETER, HeatherAddress:
Bristol BS8 1TD, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201220328Date:
12.11.2012Country:
GB
Number:
201316660Date:
19.9.2013Country:
GB
Classification
Categories:
C07K 14/755, A61K 38/00, A61K 39/00, A61K 38/37
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 5.10.2017
Expires: 10.11.2018
Payer: Árnason Faktor
Number: 6
Paid: 5.10.2018
Expires: 10.11.2019
Payer: Árnason Faktor